The United Laboratories International Holdings Limited (3933.HK)
3933.HK Stock Price Chart
Explore The United Laboratories International Holdings Limited interactive price chart. Choose custom timeframes to analyze 3933.HK price movements and trends.
3933.HK Company Profile
Discover essential business fundamentals and corporate details for The United Laboratories International Holdings Limited (3933.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
15 Jun 2007
Employees
17.00K
Website
https://www.tul.com.cnCEO
Hoi Shan Tsoi
Description
The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.
3933.HK Financial Timeline
Browse a chronological timeline of The United Laboratories International Holdings Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 23 Mar 2026
Dividend declared on 25 Sept 2025
A dividend of $0.17 per share was announced, adjusted to $0.17. The dividend will be paid on 1 Oct 2025.
Earnings released on 28 Aug 2025
EPS came in at $1.14 falling short of the estimated $1.46 by -21.92%, while revenue for the quarter reached $8.24B , missing expectations by -4.81%.
Dividend declared on 8 Jul 2025
A dividend of $0.31 per share was announced, adjusted to $0.31. The dividend was paid on 23 Jul 2025.
Earnings released on 24 Mar 2025
EPS came in at $0.68 falling short of the estimated $0.83 by -17.59%, while revenue for the quarter reached $7.00B , missing expectations by -12.28%.
Dividend declared on 19 Sept 2024
A dividend of $0.18 per share was announced, adjusted to $0.18. The dividend was paid on 15 Oct 2024.
Earnings released on 29 Aug 2024
EPS came in at $0.88 surpassing the estimated $0.82 by +7.83%, while revenue for the quarter reached $7.71B , missing expectations by -1.46%.
Dividend declared on 2 Jul 2024
A dividend of $0.44 per share was announced, adjusted to $0.44. The dividend was paid on 24 Jul 2024.
Earnings released on 26 Mar 2024
EPS came in at $0.86 surpassing the estimated $0.80 by +7.47%, while revenue for the quarter reached $7.56B , missing expectations by -53.57%.
Dividend declared on 14 Sept 2023
A dividend of $0.13 per share was announced, adjusted to $0.13. The dividend was paid on 11 Oct 2023.
Earnings released on 29 Aug 2023
EPS came in at $0.76 surpassing the estimated $0.38 by +102.01%, while revenue for the quarter reached $7.47B , beating expectations by +27.53%.
Dividend declared on 4 Jul 2023
A dividend of $0.15 per share was announced, adjusted to $0.15. The dividend was paid on 26 Jul 2023.
Earnings released on 21 Mar 2023
EPS came in at $0.60 surpassing the estimated $0.32 by +88.01%, while revenue for the quarter reached $7.01B , missing expectations by -48.00%.
Dividend declared on 15 Sept 2022
A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 6 Oct 2022.
Dividend declared on 5 Jul 2022
A dividend of $0.09 per share was announced, adjusted to $0.09. The dividend was paid on 20 Jul 2022.
Earnings released on 30 Jun 2022
EPS came in at $0.40 surpassing the estimated $0.33 by +23.29%, while revenue for the quarter reached $6.07B , beating expectations by +7.94%.
Earnings released on 31 Dec 2021
EPS came in at $0.24 falling short of the estimated $0.37 by -34.03%, while revenue for the quarter reached $6.10B , beating expectations by +1.40%.
Dividend declared on 16 Sept 2021
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 8 Oct 2021.
Dividend declared on 6 Jul 2021
A dividend of $0.10 per share was announced, adjusted to $0.10. The dividend was paid on 15 Jul 2021.
Earnings released on 30 Jun 2021
EPS came in at $0.41 surpassing the estimated $0.31 by +30.08%, while revenue for the quarter reached $5.67B , beating expectations by +0.06%.
Earnings released on 31 Dec 2020
EPS came in at $0.32 falling short of the estimated $0.36 by -9.11%, while revenue for the quarter reached $5.31B , missing expectations by -6.51%.
3933.HK Stock Performance
Access detailed 3933.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.